Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

Hannes Leischner, Corinna Albers, Rebekka Grundler, Elena Razumovskaya, Karsten Spiekermann, Stefan Bohlander, Lars Rönnstrand, Katharina Götze, Christian Peschel, Justus Duyster

Blood (2012) 119 (17): 4026–4033.

https://doi.org/10.1182/blood-2011-07-365726

Published: 2012

Includes: Supplemental data

Journal Articles

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

Corinna Albers, Anna L. Illert, Cornelius Miething, Hannes Leischner, Melanie Thiede, Christian Peschel, Justus Duyster

Blood (2011) 118 (8): 2200–2210.

https://doi.org/10.1182/blood-2010-10-309583

Published: 2011

Includes: Supplemental data

Journal Articles

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

Corinna Albers, Anna Lena Illert, MD, Hannes Leischner, Cornelius Miething, MD, Richard Huss, Christian Peschel, MD, Justus Duyster, MD

Blood (2010) 116 (21): 3392.

https://doi.org/10.1182/blood.V116.21.3392.3392

Published: 2010

Journal Articles

Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells

Hannes Leischner, Rebekka Grundler, Corinna Albers, Anna Lena Illert, MD, Katharina Götze, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2010) 116 (21): 2892.

https://doi.org/10.1182/blood.V116.21.2892.2892

Published: 2010

Journal Articles

SRC Is a Critical Signaling Mediator in FLT3-ITD Positive AML.

Hannes Leischner, Rebekka Grundler, Ph.D, Corinna Albers, Anna Lena Illert, Karsten Spiekermann, MD, Christian Peschel, MD, Justus Duyster, MD

Blood (2009) 114 (22): 477.

https://doi.org/10.1182/blood.V114.22.477.477

Published: 2009

NARROW

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells

SRC Is a Critical Signaling Mediator in FLT3-ITD Positive AML.

Email alerts

ASH Publications

American Society of Hematology

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL–driven leukemogenesis

A Single Retroviral Vector Design for the Simultaneous Expression of a Mir30 Based Shrna with An Oncogene – Identification of Raf-1 but Not BRAF as a Crucial Mediator for BCR-ABL Mediated Leukemogenesis.

Combination of c-SRC and FLT3 Inhibitors Has An Additive Inhibitory Effect on FLT3 ITD but Not on FLT3 TKD Positive Cells

SRC Is a Critical Signaling Mediator in FLT3-ITD Positive AML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only